IDEAYA Biosciences (IDYA) Assets Average (2019 - 2026)

IDEAYA Biosciences (IDYA) has 8 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 3.82% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 3.82% YoY), and the FY2025 full-year result was $1.1 billion, up 25.94% from the prior year.
• Assets Average declined to $1.1 billion in Q1 2026, from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.2 billion in Q4 2024 to a low of $348.4 million in Q2 2022.
• A 5-year average of $765.4 million and a median of $805.4 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 116.88% in 2024 and decreased 3.82% in 2026, its largest moves.
• Tracing IDYA's Assets Average over 5 years: stood at $399.4 million in 2022, then jumped by 47.99% to $591.1 million in 2023, then jumped by 99.95% to $1.2 billion in 2024, then declined by 2.94% to $1.1 billion in 2025, then slipped by 6.75% to $1.1 billion in 2026.
• Business Quant data shows IDYA's Assets Average at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.